oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Esmya

A case of severe liver injury in a patient using ulipristal acetate 5 mg was identified, requiring liver transplantation; there is a real, significant probability of serious harm to health or life. Potential effects: severe liver damage, liver failure, life-threatening complications.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Esmya
Risk Level
Critical
Manufacturer
Gedeon Richter Plc. Węgry
Batch Number
wszystkie serie
Recall Date
13.03.2020
View official statement

Important Information

What You Should Know

Recommendations

Do not use Esmya (ulipristal acetate) 5 mg; patients currently taking it should contact their physician for further management and liver function assessment.

Actions Taken

All batches of the medicinal product Esmya 5 mg were suspended from marketing throughout the country; the decision was given immediate enforceability; the marketing authorisation holder was obliged to...

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: A case of severe liver injury in a patient using ulipristal acetate 5 mg was identified, requiring liver transplantation; there is a real, significant probability of serious harm to health or life. Potential effects: severe liver damage, liver failure, life-threatening complications.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: wszystkie serie

Related

Other Recalled Products